The IPO I’m waiting for the most at the moment is certainly Fibrogen, a biopharmaceutical company about to become public on Friday. Biopharms have done exceptionally well in the last few months, against all expectations, and I am hoping Fibrogen to be even better. But the question remains: how much is Fibrogen worth? Before we begin, […]
